Trial Profile
Safety and tolerability of micafungin for prophylaxis of invasive fungal disease in paediatric patients undergoing allogeneic hematopoietic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Mycoses
- Focus Adverse reactions
- 12 Dec 2015 New trial record